2013-12-03 18:18:57 UTC

Liver Stiffness Can Determine Risk Level in Patients with CLDs

Dec. 5, 2013

Reporting in Clinical Gastroenterology and Hepatology, Siddharth Singh and colleagues find that the degree of liver stiffness is associated with risk of decompensated cirrhosis, hepatocellular carcinoma and death in patients with chronic liver diseases (CLDs).

Liver stiffness measurement (LSM), using elastography, can independently predict outcomes of patients with chronic liver diseases (CLDs). However, there is much variation in reporting and consistency of findings. Siddharth Singh and colleagues performed a systematic review and meta-analysis to evaluate the association between LSM and outcomes of patients with CLDs. Reporting in Clinical Gastroenterology and Hepatology, they find that the degree of liver stiffness is associated with risk of decompensated cirrhosis, hepatocellular carcinoma and death in patients with CLDs. LSM therefore might be used in risk stratification.

Clinical Gastroenterology and Hepatology 2013: 11(12): 1573-1584.e2

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.